Skip to main content

Advertisement

Table 1 Epidemiology of spasticity

From: Inequalities in pharmacologic treatment of spasticity in Sweden – health economic consequences of closing the treatment gap

ConditionPrevalence/100,000Prevalence disabling spasticity
Stroke715 [12]17% [13,14,15]
CP215 [16]23% [17]
MS190 [18]33% [19]
TBI150 [20]19% [21]
SCI32 [22, 23]31% [24, 25]
  1. Mean prevalence of disabling spasticity for all diagnoses = 271/100,000 a)
  2. Abbreviations: MS (multiple sclerosis), CP (cerebral palsy), SCI (spinal cord injury), TBI (traumatic brain injury)
  3. aAssuming an even distribution in disabling spasticity across healthcare regions